This paper explores the relationship between investing in pharmaceutical manufacturing risk reduction and meeting business objectives.
David Lebo
Advertisement
David Lebo, PhD is Professor of Pharmaceutics, Temple University School of Pharmacy.
Articles by David Lebo
Advertisement
Latest Updated Articles
ICH Q9: Attaining a Quality-Business Synergy through Quality Risk Management, ROI Analysis, and Highly Capable FacilitiesPublished: January 15th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
AAPS PharmSci 360 2025: Trends in Bioanalysis
4
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
5
